IMPACTS OF PHARMACEUTICAL CARE IN TYPE 2 DIABETES MELLITUS ON THE SUS’ PRIMARY ATTENTION IN A MUNICIPALITY IN PARANÁ’S COUNTRYSIDE

Abstract

Introduction: The Brazilian Unified Health System (SUS) plays a - role in health promotion, including the care of chronic noncommunicable diseases such as diabetes mellitus, in which Pharmaceutical Care may contribute to improved health outcomes. Objective: To identify problems in self-care among individuals with type 2 diabetes mellitus (DM2), develop appropriate management strategies, prevent complications, and promote clinical pharmaceutical services. Methods: A quasi-experimental clinical study was conducted between January and December 2022 with 36 individuals with DM2 undergoing medical treatment and presenting ineffective glycemic control, followed at the Jeovah Ribeiro Municipal Basic Pharmacy in Castro, Paraná, Brazil. Glycated hemoglobin (HbA1c) and fasting glucose (FG) levels were analyzed using the Wilcoxon test, considering p<0.05. Results: A reduction in HbA1c levels was observed in 26 (72.23%) participants, while 9 (25%) showed worsening and 1 (2.77%) showed no change. Improvements were observed in dietary habits, regular physical activity practice, and medication adherence, which increased from 4 (11.11%) to 28 (77.78%) participants at the end of pharmacotherapeutic follow- up. Conclusion: Pharmaceutical Care integrated into a multidisciplinary team showed positive results, with reductions in HbA1c levels, contributing to the minimization of risks associated with complications chronic noncommunicable diseases such as DM2.